 According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD)  by reproductive-age women is on the rise. [...]
For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we often recommend discontinuing stimulant medications and switching to a non-pharmacologic intervention. Â Many women experience some decrease in their level of functioning; however, they are [...]
For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we typically recommend discontinuing medication and switching to a nonpharmacologic intervention. Â Although these women might experience some decrease in their level of functioning, they are [...]
Many women report cognitive difficulties -- forgetfulness, distractibility, feeling foggy ---during the transition to menopause. While much attention has been devoted to the treatment of vasomotor symptoms, such as hot flashes or night sweats, less [...]
For women with mild to moderate attention-deficit/hyperactivity disorder (ADHD) symptoms, we frequently recommend discontinuing medication and switching to a non-pharmacologic intervention. Although these women might experience some decrease in their level of functioning, they typically [...]
Approximately 4% of the adult population suffers from ADHD. Attention and executive functioning difficulties also occur in those with mood and psychotic disorders and require treatment strategies similar to those used to address ADHD symptoms. First line medications most often used to treat ADHD in adults are Dextroamphetamine (Dexedrine, Adderall) and Methylphenidate (Concerta, Ritalin, Metadate).
